Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRILLIANT Study
NCT06696716Phase 3Active, not recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Aug 2022
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirabrutinib in pemphigus, sponsored by Ono Pharmaceutical. Started Aug 2022; status: active, not recruiting.
02
Drugs
tirabrutinib
03
Conditions
pemphigus
Beyond the preview
Go deeper on NCT06696716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06696716.